TY - JOUR
T1 - Leg vasoconstriction during dynamic exercise with reduced cardiac output
AU - Pawelczyk, J. A.
AU - Hanel, B.
AU - Pawelczyk, R. A.
AU - Warberg, J.
AU - Secher, N. H.
PY - 1992
Y1 - 1992
N2 - We evaluated whether a reduction in cardiac output during dynamic exercise results in vasoconstriction of active skeletal muscle vasculature. Nine subject performed four 8-min bouts of cycling exercise at 71 ± 12 to 145 ± 13 W (40-84% maximal oxygen uptake). Exercise was reported after cardioselective (β1) adrenergic blockade (0.2 mg/kg metoprolol iv). Leg blood flow and cardiac output were determined with bolus injections of indocyanine green. Femoral arterial and venous pressures were monitored for measurement of heart rate, mean arterial pressure, and calculation of systemic and leg vascular conductance. Leg norepinephrine spillover was used as an index of regional sympathetic activity. During control, the highest heart rate and cardiac output were 171 ± 3 beats/min and 18.9 ± 0.9 l/min, respectively. β1-Blockade reduced these values to 147 ± 6 beats/min and 15.3 ± 0.9 l/min, respectively (P < 0.001). Mean arterial pressure was lower than control during light exercise with β1-blockade but did not differ from control with greater exercise intensities. At the highest work rate in the control condition, leg blood flow and vascular conductance were 5.4 ± 0.3 l/min and 5.2 ± 0.3 cl · min-1 · mmHg-1, respectively, and were reduced during β1-blockade to 4.8 ± 0.4 l/min (P < 0.01) and 4.6 ± 0.4 cl · min-1 · mmHg-1 (P < 0.05). During the same exercise condition leg norepinephrine spillover increased from a control value of 2.64 ± 1.16 to 5.62 ± 2.13 nM/min with β1-blockade (P < 0.05). At least one-third of the increase in mean arterial pressure during exercise with β1-blockade could be accounted for by leg vasoconstriction. We concluded that neurogenic vasoconstriction of active skeletal muscle can offset metabolic vasodilation during intense dynamic exercise when cardiac output is compromised.
AB - We evaluated whether a reduction in cardiac output during dynamic exercise results in vasoconstriction of active skeletal muscle vasculature. Nine subject performed four 8-min bouts of cycling exercise at 71 ± 12 to 145 ± 13 W (40-84% maximal oxygen uptake). Exercise was reported after cardioselective (β1) adrenergic blockade (0.2 mg/kg metoprolol iv). Leg blood flow and cardiac output were determined with bolus injections of indocyanine green. Femoral arterial and venous pressures were monitored for measurement of heart rate, mean arterial pressure, and calculation of systemic and leg vascular conductance. Leg norepinephrine spillover was used as an index of regional sympathetic activity. During control, the highest heart rate and cardiac output were 171 ± 3 beats/min and 18.9 ± 0.9 l/min, respectively. β1-Blockade reduced these values to 147 ± 6 beats/min and 15.3 ± 0.9 l/min, respectively (P < 0.001). Mean arterial pressure was lower than control during light exercise with β1-blockade but did not differ from control with greater exercise intensities. At the highest work rate in the control condition, leg blood flow and vascular conductance were 5.4 ± 0.3 l/min and 5.2 ± 0.3 cl · min-1 · mmHg-1, respectively, and were reduced during β1-blockade to 4.8 ± 0.4 l/min (P < 0.01) and 4.6 ± 0.4 cl · min-1 · mmHg-1 (P < 0.05). During the same exercise condition leg norepinephrine spillover increased from a control value of 2.64 ± 1.16 to 5.62 ± 2.13 nM/min with β1-blockade (P < 0.05). At least one-third of the increase in mean arterial pressure during exercise with β1-blockade could be accounted for by leg vasoconstriction. We concluded that neurogenic vasoconstriction of active skeletal muscle can offset metabolic vasodilation during intense dynamic exercise when cardiac output is compromised.
UR - http://www.scopus.com/inward/record.url?scp=0026457573&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026457573&partnerID=8YFLogxK
U2 - 10.1152/jappl.1992.73.5.1838
DO - 10.1152/jappl.1992.73.5.1838
M3 - Article
C2 - 1474060
AN - SCOPUS:0026457573
SN - 0161-7567
VL - 73
SP - 1838
EP - 1846
JO - Journal of applied physiology
JF - Journal of applied physiology
IS - 5
ER -